Stemolecule™ PD0325901 in Solution
Add To Cart |
Order Offline
T: 877.228.9783
F: 617.812.5900 E: orders@stemgent.com |


Product Overview
PD0325901 is a small molecule targeting mitogen-activated protein kinase (MAPK/ERK kinase or MEK) with potential antineoplastic activity. PD0325901, a derivative of MEK inhibitor CI-1040, selectively binds to and inhibits MEK, which may result in the inhibition of the phosphorylation and activation of MAPK/ERK and the inhibition of tumor cell proliferation1,2. Along with the ALK5 inhibitor SB431542, PD0325901 has also been shown to increase the efficiency of reprogramming human primary fibroblasts into induced pluripotent stem (iPS) cells3.
Stemolecule PD0325901 in Solution is a ready to use 10 mM stock solution for stem cell culture.
Product Specifications
Size
2 mg
Concentration
10 mM in DMSO
Alternate Name
N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide
Chemical Formula
C16H14F3IN2O4
Molecular Weight
482.19
CAS Number
391210-10-9
Purity
Greater than 97% by HPLC analysis
Formulation
10 mM solution of PD0325901 in DMSO (2 mg in 414.8 μl)
Handling
Before opening, briefly centrifuge the vial to ensure full recovery of sample. Aliquotting the stock solution is recommended to avoid repetitive freeze-thaw cycles. For cell culture, the media should be prewarmed prior to adding the reconstituted compound. Note: for most cells, the maximum tolerance to DMSO is less than 0.5%.
Storage and Stability
Store solution at -20°C protected from light. Stable for 6 months from date of receipt when stored as directed.
Quality Control
The purity of PD0325901 was determined by HPLC analysis. The accurate mass was determined by mass spectrometry. Cellular toxicity of PD0325901 was tested on mouse embryonic stem cells.
References
- Bain, J., Plater, L., Elliott, M., Hastie, C.J., McLauchlan, H., Klevernic, I., Arthur, J.S., Alessi, D.R., and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update.Biochem. J. 408: 297-315.
- Sebolt-Leopold, J.S. and Herrera, R. (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4: 937-947.
- Lin, T., Ambasudhan, R., Yuan, X., Li, W., Hilcove, S., Abujarour, R., Lin, X., Hahm, H.S., Hao, E., Hayek, A., and Ding, S. (2009) A chemical platform for improved induction of human iPSCs. Nat Methods 6: 805-808.
Additional Publications
Customers Also Purchased
04-0004
|
|
2 mg | $203.00 |
04-0006
|
|
2 mg | $203.00 |
08-0028
|
|
1.0 x 106 cells/vial | $499.00 |
04-0074
|
|
2 mg | $203.00 |
04-0004-02
|
|
2 mg (10 mM) | $239.00 |
Stemgent Comments and Reviews (0)
No comments or reviews yet. Be the first to leave a review.
Add a Comment
You must log-in or register as a Stemgent member to submit a comment.
You are fully responsible for the content you post. We encourage collaboration and helpful reviews among scientists and will use this feature to conduct helpful reviews of our products. Content that includes profanity, personal attacks or antisocial behavior (such as "spamming" or "trolling"), or other inappropriate content or material will be removed. We reserve the right to block any user who violates our terms of use, including removing all content posted by that user.